Novartis announced today that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates…View More Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals
Eisai Co., Ltd. announced today that it has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride…View More EISAI AND CY BIOTECH SIGNS AN AGREEMENT FOR ANTI-OBESITY AGENT LORCASERIN IN CHINA
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2018 financial and operating results on Thursday, August 2, 2018, before the U.S. financial…View More Regeneron to Report Second Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on August 2, 2018
Alcon Cares to donate 100 reprocessed Infiniti® units to clinics helping underserved patients in Asia, Central and South America, and Africa over the next three…View More Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Fresenius Kabi has started work on a major expansion of its production site for medical devices in Haina, Dominican Republic, which will create about 500…View More Fresenius Kabi expands production site for medical devices in Dominican Republic
Eli Lilly and Company (NYSE: LLY) and Indiana University’s Richard M. Fairbanks School of Public Health at IUPUI announced today the launch of a new neighborhood-based, data-driven pilot…View More Lilly and Local Partners Launch Diabetes Prevention and Management Pilot in Three Undeserved Neighborhoods in Indianapolis.
Johnson & Johnson (NYSE: JNJ) will participate in the 2018 UBS Global Health Care Conference on Monday, May 21st, at the Grand Hyatt, New York.…View More Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference